Corinne Cather, PhD

Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts

  • 8Articles
  • 20KReads
  • 2004–2026Active
  • 28Collaborators
  • 23Citations

About

Corinne Cather, PhD, is affiliated with the Department of Psychiatry at Massachusetts General Hospital in Boston, Massachusetts. Her publications from 2004 to 2026 focus on schizophrenia and schizoaffective disorders, addiction, metabolic and psychotic disorders, and weight management. Her research topics include criminal legal involvement in first-episode psychosis, tobacco abstinence effects in serious mental illness, glucose metabolism in patients treated with antipsychotics, cognitive function related to tobacco abstinence and bupropion, and medical morbidity in schizophrenia. She has frequently collaborated with authors such as A. Eden Evins, Donald C. Goff, and Oliver Freudenreich.

Publications

JCP
Correlates and Predictors of Criminal Legal Involvement in First-Episode Psychosis
Original Research

Correlates and Predictors of Criminal Legal Involvement in First-Episode Psychosis

March 30, 2026

More than 10% of people with first-episode psychosis are involved in the legal system before (11%) and while (14%) receiving mental health treatment, which can interrupt access to specialty...
, ,
JCP
Original Research

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

March 23, 2016

, , , et al
JCP
Original Research

Predictors of Early Abstinence in Smokers With Schizophrenia

November 30, 2008

, , , et al
JCP
Original Research

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

May 15, 2006

, , , et al
JCP
Original Research

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

September 15, 2005

, , , et al
JCP
Original Research

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

February 15, 2005

, , , et al
JCP
Original Research

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

October 15, 2004

, , , et al
JCP
Original Research

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

March 1, 2004

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe